medical marijuana

Biotech January 25, 2018

Smoking-hot biotech sparks key cannabis contract

By GREGORY ZELLER // It’s another new high for Applied DNA Sciences. Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the Stony Brook-based biotech lit up again Thursday, announcing a new contract to develop molecular tracking systems for a worldwide network of legal cannabis supplies. The two-year, $1 million development and marketing agreement with Canadian supplier TheraCann International Benchmark Corp. – which provides turn-key pharmaceutical solutions…

Pharma August 1, 2017

State green-lights LI med-marijuana dispensaries

New medical marijuana dispensaries are coming to Long Island. The New York State Department of Health on Tuesday announced that it has authorized five “registered organizations” – permitted by state statute to manufacture medical marijuana and manage up to four dispensaries each – to operate new dispensaries across the state. Several companies on the list plan to operate in Nassau and Suffolk counties, with as many as four new dispensaries about to crop up on…

Biotech March 14, 2017

Stock deal locks funds for Scythian marijuana study

By GREGORY ZELLER // A Canadian R&D firm with Long Island roots has locked up the first tranche of a strategic investment that will fund a major study involving concussions and medical marijuana. Scythian Biosciences Inc. and Canadian mining exploration company Kitrinor Metals Inc. on Tuesday announced a “brokered private placement” that gives 32.7 million common shares of Calgary-based Scythian, owned by Great Neck investment banker Jonathan Gilbert, to an investment team including lead agent…

Biotech December 18, 2016

Tackling concussions with cannabis

By GREGORY ZELLER // A research effort stretching from Florida to Long Island to Canada’s Alberta province will determine if compounds derived from marijuana can be effective treatments for concussions. Calgary-based R&D firm Scythian Biosciences has agreed to fund a University of Miami study, to be conducted by the university’s The Miami Project to Cure Paralysis and Miller School of Medicine, exploring cannabinoid-based methods of reducing post-concussion brain cell inflammation, which causes headaches and other neurological complications….